Similar Articles |
|
The Motley Fool February 22, 2005 Chuck Saletta |
Three Tens for a Twenty What does it take to cash in on Wall Street's mood swings? Value investors with the right mix of objectivity, confidence, and patience can often profit from the Street's mistakes. |
The Motley Fool January 19, 2005 Chuck Saletta |
Why Value Wins How a disciplined, value-focused approach to investing can turn the odds in your favor. |
The Motley Fool March 2, 2005 Chuck Saletta |
Why Value Wins How a disciplined, value-focused approach to investing can turn the odds in your favor. |
The Motley Fool July 13, 2005 Chuck Saletta |
How to Buy Low and Sell High Use Ben Graham's margin of safety to buy and sell stocks profitably. |
The Motley Fool November 12, 2004 Chuck Saletta |
Three Magical Words Margin of safety are the three most important words in value investing. |
The Motley Fool October 6, 2005 Chuck Saletta |
Waiting on Greatness Waiting is often the hardest part of investing. But it's also usually the most lucrative. |
The Motley Fool May 6, 2005 Rich Duprey |
A Patient Investor's Guide to Profit One simple virtue can lead you to the right stock at the right price. All too often, investors try to hurry up and climb aboard the latest growth-stock rocket ship only to get burned as it plummets back to Earth. |
The Motley Fool January 26, 2005 Richard Gibbons |
How to Outperform in 2005 Here are five tips to help investors identify stocks that are set to trounce the market. |
The Motley Fool October 4, 2004 Mathew Emmert |
Got Merck? The pharmaceutical's investors can't seem to catch a break. |
The Motley Fool November 23, 2004 Chuck Saletta |
Stocks on Sale Investing should be like shopping: Know what you want, then buy it at a discount. |
The Motley Fool February 24, 2005 David Meier |
Got Value? Value investing is the best way to play. Is it in you? As an investor, your goal is to have your investments outperform the market. Have you got value to help you achieve them? |
The Motley Fool September 27, 2005 Chuck Saletta |
Superman Can't Save You The largest and most powerful advantage we have over the market, the one that's nearly universally fatal for institutional investors, is really quite simple. It's time. |
The Motley Fool June 1, 2005 Chuck Saletta |
Where Angels Fear to Tread In the right situation, short-term corporate crises can provide superior long-term possibilities. Of course, investing in companies in crisis comes with risk. |
The Motley Fool May 27, 2005 Nick Baker |
Mama Always Said You'd Go Blind Urban legends aside, what do new concerns about Viagra and Cialis mean for investors? |
The Motley Fool December 23, 2004 Rich Duprey |
Masonite Opens Door for Buyout The door maker will go private in a $2.5 billion deal. |
The Motley Fool November 9, 2005 Chuck Saletta |
Cover Your Assets The key point for building a successful value portfolio is determining how to reduce your risk without reducing your expected return along the way. Commission-hungry brokers often sell a strategy known as portfolio insurance, the purchase of derivative securities called "put options," to reduce an investor's risk of loss. |
The Motley Fool November 4, 2005 Chuck Saletta |
Know Your Enemy If you want to minimize the number of mistakes you make in your investing choices, you have to keep a firm grasp on what a company you're considering is really worth. |
The Motley Fool February 10, 2005 Chuck Saletta |
Never Fall in Love The result of falling in love with stocks is often pain and suffering. Fortunately for the value-seeking investor, there are always a few bargains waiting in the wings. |
The Motley Fool December 17, 2004 W.D. Crotty |
Painful Pain Drugs Pfizer joins Merck in the COX-2 inhibitor penalty box. Pfizer's stock, has drifted down since the Vioxx news. |
The Motley Fool December 21, 2004 Seth Jayson |
Buy Drug Fears? When headlines get bad, both value hunters and rule breakers should start feeling good about buying stock. |
The Motley Fool March 1, 2006 Rich Duprey |
Celebrex Doubles Lawsuit Risk A new study says the Pfizer painkiller doubles the risk of a heart attack. Investors, beware. |
The Motley Fool September 14, 2005 Chuck Saletta |
History Repeats Itself The greatest market-beating investors have all focused on value principles. Why should the future be any different? |
The Motley Fool December 28, 2004 W.D. Crotty |
Pfizer: For Value Eyes Only While clearly not for conservative investors, this pharmaceutical deserves the attention of those looking for a value play. |
The Motley Fool November 29, 2005 Shannon Zimmerman |
Can FedEx Deliver? Is this transportation giant's price right? Investors, take note. |
The Motley Fool January 28, 2005 Philip Durell |
Tom Gardner Interviews Philip Durell Tom and the author get together to talk value investing. |
The Motley Fool November 18, 2004 Lawrence Meyers |
Sympathy for Pfizer The market acts like Vioxx, Bextra, and Celebrex are the same drugs. They're not. Investors should change direction. |
The Motley Fool May 18, 2004 Selena Maranjian |
Places for Great Investment Ideas There are some good investment newsletters out there, even from us. |
The Motley Fool June 15, 2006 Roger Friedman |
The Battle Between Phil and Tiger While Great Wolf and Overstock have become sidetracked in their growth stories and disappointed investors, Archipelago's gains have more than made up for it. These are high-risk, high-reward scenarios. What kind of investor are you? |
The Motley Fool August 17, 2005 Chris Mallon |
Your Best Investment Tool A watch list can be a huge help in making smart investment decisions. |
The Motley Fool May 31, 2005 Tim Beyers |
2 Things I Learned From Benjamin Graham Warren Buffett's mentor pioneered the idea of buying stocks on sale, and his books have provided dozens of lessons for investors over the years. The author shares two that have changed his investment life. |
The Motley Fool March 23, 2005 Chuck Saletta |
Catching the Hot Potatoes Diversification can protect your portfolio from the worst of a company's stumbles. |
The Motley Fool March 16, 2005 Rich Duprey |
Mergers and Acquiescence Are investors better off holding or selling their stocks that are getting acquired? |
The Motley Fool December 21, 2004 Brian Gorman |
Pfizer Won't Let Go Pfizer is hoping that Celebrex will survive in some form. But the pharmaceutical giant has also determined that the drug should no longer be advertised to consumers. Its shares were pounded again following its revelation that it would pull such ads. |
The Motley Fool November 5, 2004 Selena Maranjian |
10 Big Investing Mistakes Some mistakes are not always mistakes. |
The Motley Fool February 15, 2006 Selena Maranjian |
Juice Your Investing Abilities Some ways to improve your stock picking and some mistakes to avoid. |
The Motley Fool May 10, 2005 |
Fair Value, Explained Don't confuse a stock's price with its fair value. |
The Motley Fool January 14, 2005 Chuck Saletta |
Controlling the Carnage Relying on perpetually rosy scenarios can kill a portfolio. Value investing offers a way out. |
The Motley Fool January 25, 2006 Tim Hanson |
Find the Silver Lining Falling stock prices don't have to be all bad news. While market drops can test your will, it's always best to keep a level head. |
The Motley Fool October 22, 2004 Chuck Saletta |
When Crystal Balls Break Proper diversification is one method by which investors can reduce the risk to their portfolio as a whole without significantly compromising their overall expected returns, making it a key tool for any value investor's kit. |
The Motley Fool January 5, 2005 Chuck Saletta |
Sominex for Your Portfolio Investing is a risky activity. Make sure your stocks don't keep you up at night. |
The Motley Fool March 2, 2006 Chuck Saletta |
Shot Through the Heart The market doesn't care what you paid for a stock. Thinking otherwise can hurt you. All that matters over time is what the stock is worth, compared to where it happens to be trading. |
The Motley Fool July 2, 2004 Chris Mallon |
Patience Is Profitable It can take Mr. Market years to realize the value of your investments, so just be patient. |
The Motley Fool February 24, 2005 Chuck Saletta |
Controlling the Carnage Relying on perpetually rosy scenarios can kill a portfolio. Value investing offers a way out. |
The Motley Fool December 10, 2004 Selena Maranjian |
Types of Investors: Which Are You? Knowing who you are can help you understand yourself and how you approach making money. Learn about some classifications of investors and which brokerage is right for you. |
The Motley Fool June 3, 2005 Tim Beyers |
Let's Hear It for Joe Oddlot Don't let anyone tell you that you need to be on Wall Street to be a superior investor. You don't. Think you can't possibly beat the market, right? Balderdash. |
The Motley Fool February 17, 2005 W.D. Crotty |
Coke's a Value Stock Coca-Cola management expresses disappointment, but signs point to fizzier times ahead. With improving margins, and with Coke selling for 20.3 times free cash flow to enterprise value (vs. 27.3 times for Pepsi), the stock is still value-priced. |
The Motley Fool March 30, 2005 Tim Beyers |
How I Learned to Invest Anyone can become an investor. If you have the guts to try, here is a plan to help you get started. |
The Motley Fool October 12, 2006 Tim Hanson |
5 Turnaround Stocks These stocks are down, but not out: Bausch & Lomb... Compucredit... Intersections... Syneron Medical... etc. |
The Motley Fool July 20, 2005 Chuck Saletta |
Beat the House at Its Own Game Investing will always be risky. You can't eliminate that, but you can tilt the odds in your favor with value investing. |
The Motley Fool October 11, 2005 Chuck Saletta |
Respect the Market Stocks' prices move both up and down in ways that are simply out of our control, although they do eventually seek a fair level. Learn to judge when a company's stock is below that fair level and when it's above, and you, too, can profit as a value investor. |